Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole in Non-alcoholic Steatohepatitis
NCT06302049Phase 2Recruiting
- Sponsor
- Sadat City University
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esomeprazole in Nonalcoholic steatohepatitis (NASH), sponsored by Sadat City University. Started Jun 2024; status: recruiting.
02
Drugs
esomeprazole
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT06302049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06302049.